Synthesis and in Vitro Biological Activities of 4,5-Disubstituted 1,2,4-Triazole-3-Thiols

Abstract Full-Text HTML Download Download as PDF (Size:321KB) PP. 366-375
DOI: 10.4236/aim.2013.34050    3,703 Downloads   6,151 Views   Citations


Purpose: The triazole nucleus is an important part of the therapeutically interesting drug candidate as antimicrobial, analgesic, anticancer, anticonvulsant and anti-inflammatory agents. Methods: Therefore, in this study, twelve 4,5-disubstituted-1,2,4-triazole-3-thiols were synthesized by the reaction of substituted isothiocyanates and hydrazides using the common method of base catalysed intramolecular dehydrative cyclization of substituted thiosemicarbazides 3(a-f) and 4(a-f). The structures of these compounds were characterized by means of FT-IR, 1H-NMR, and elemental analysis data. All these compounds were screened for antibacterial, antioxidant, antitumor and cytotoxic activities. Results: Among these compounds: 5c, 5f and 6f were found active against gram positive cocci, the compounds 5a, 5b, 5d, 6a and 6f showed 85% free radical scavenging effect at 3 ppm when tested for antioxidant activity, 75% tumors inhibition was recorded using 5c, 5d and 6a and brine shrimps lethality assay declared 5a, 5b and 6d was 129.62 μg/ml, 161.577 μg/ml and 81.56 μg/ml respectively. Conclusion: Compounds carrying significant bioactivity can be further studied using animal models to establish their safety profile prior to initiating clinical trials.

Cite this paper

H. Nadeem, M. Mohsin, H. Afzaal, S. Riaz, A. Zahid and S. Muhammad, "Synthesis and in Vitro Biological Activities of 4,5-Disubstituted 1,2,4-Triazole-3-Thiols," Advances in Microbiology, Vol. 3 No. 4, 2013, pp. 366-375. doi: 10.4236/aim.2013.34050.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] N. D. Heindel and J. R. Reid, “4-Amino-3-Mercapto-4H-1,2,4-Triazoles and Propargyl Aldehydes: A New Route to 3-R-8-Aryl-1,2,4-Triazolo[3,4-b]-1,3,4-Thiadiazepines,” Journal of Heterocyclic Chemistry, Vol. 17, No. 5, 1980, p. 1087. doi:10.1002/jhet.5570170547
[2] B. S. Holla, B. Kalluraya, K. R. Sridhar, E. Drake, L. M. Thomas, K. K. Bhandary and M. S. Levine, “Synthesis, Structural Characterization, Crystallographic Analysis and Antibacterial Properties of Some Nitrofuryl Triazolo [3,4-b]-1,3,4-Thiadiazines,” European Journal of Medicinal Chemistry, Vol. 29, No. 4, 1994, pp. 301-308.
[3] J. Haber, “Present Status and Perspectives on Antimycoties with Systematic Effects,” Casopis Lekaru Ceskych, Vol. 140, No. 19, 2001, pp. 596-604.
[4] A. Brucato, A. Coppola, S. Gianguzza and P. M. Provenzan, “Triazolam: Characteristics of Its Depressive Action,” Bollettino della Società italiana di biologia sperimentale, Vol. 54, No. 11, 1978, pp. 1051-1057.
[5] D. L. Coffen and R. I. Fryer, US Patent (1974) 3(849): 434, Chemical Abstracts, 1975, 82: 730044v.
[6] M. Shiroki, T. Tahara and K. Araki, Japanese Patent NO. 75100096, 1975, Chemical Abstracts, 84: 59588k.
[7] F. D. Povelitsa and A. G. Gural, “Antibiotiki,” Moscow, 1973;18,71; Chemical Abstracts, 78, 93044.
[8] R. M. Shaker. “The Chemistry of Mercaptoand ThioneSubstituted 1,2,4-Triazoles and Their Utility in Heterocyclic Synthesis,” ARKIVOC, No. 9, 2006, pp. 59-112. doi:10.3998/ark.5550190.0007.904
[9] G. Mazzone, F. Bonina, R. R. Arrigo and G. Blandino “Synthesis of 1-Aroyl-4H(R)-Thiosemicarbazides, the Corresponding 5-Aryl 4H(R)-1,2,4-Triazolin-3-Thiones and Some Derivatives of Pharmaceutical Interest,” Farmaco-Edizione Scientifica, Vol. 36, No. 3, 1981, pp. 181-196.
[10] S. Narayanaswami and K. Richardson, European Patent, 1983, 96:569; Chemical Abstracts, 1984. 100: 139122t.
[11] M. B. Gravestock, European Patent, 1983, 94:146, Chemical Abstracts, 1984, 100: 139118w.
[12] R. Sharma, D. P. Nagde and G. L. Talesara, ARKIVOC, Vol. 1, 2006, pp. 1-12.
[13] K. S. Sen, F. S. Haque and C. S. Pal, “Nutrient Optimization for Production of Broad Spectrum Antibiotics by Streptomyces Antibiotics Strain 154,” Acta Microbiologica et Immunologica Hungarica, Vol. 42, No. 2, 1995, pp. 155-162.
[14] A. W. Bauer, W. M. Kirby, J. C. Sherries and M. Truck, “Antibiotic Susceptibility Testing by a Standardized Single Disk Method,” American Journal of Clinical Pathology, Vol. 45, No. 4, 1996, pp. 426-493.
[15] A. Braca, N. De Tommasi, L. Di Bari, C. Pizza, M. Politi and I. Morelli, “Antioxidant Principles from Bauhinia Terapotensis,” Journal of Natural Products, Vol. 64, No. 7, 2001, pp. 892-895. doi:10.1021/np0100845
[16] J. L. Mclaughlin and L. L. Rogers, “The Use of Biological Assays to Evaluate Botanicals,” Drug Information Journal, Vol. 32, No. 2, 1998, pp. 513-524.
[17] B. N. Meyer, N. R. Ferrigni, J. E. Putnam, L. B. Jacobsen, D. E. Nichols and J. L. McLaughlin, “Brine Shrimp: A Convenient General Bioassay for Active Plant Constituents,” Planta Medica, Vol. 45, No. 5, 1982, pp. 31-34. doi:10.1055/s-2007-971236
[18] D. J. Finney, “Probit Analysis,” Cambridge University Press, Cambridge, 1971.
[19] H. O. Oladimeji, R. Nia and E. E. Essien, “In Vitro Anti-Microbial and Brine-Shrimp Lethality Potential of the Leaves and Stem of Calotropis procera (Ait),” African Journal of Biomedical Research, Vol. 9, No. 3, 2006, pp. 205-211.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.